The disruption of the interaction between CBP and β/γ-catenin by PRI-724 can cause a decrease in self-renewal capability in leukemia-initiating cells in CML and eradication of drug-resistant primary CML cells [198]. Here, CREBBP is linked to chronic myelogenous leukemia, BCR-ABL1 positive.